Alogliptin
Alogliptin is listed as Nesina, in 12.5mg and 25mg tablets for Type 2 Diabetes Mellitus. It is a DPP-4 inhibitor, like sitagliptin and linagliptin.
Medicine containing Alogliptin
Key points
- Alogliptin raises insulin and lowers glucagon when blood sugar is high, by slowing the breakdown of the body’s own incretin hormones.
- It leaves mainly through the kidneys, so the lower strength is used when kidney function is reduced.
- Tell your doctor about heart failure before starting: alogliptin has carried a warning about heart failure.
Side effects to know
Headache, a blocked nose and upper respiratory infections are common. Rarely it can inflame the pancreas or affect the liver: severe stomach pain, or yellow skin or eyes, need urgent care.
Further reading
Last updated